Iovance Biotherapeutics (IOVA) Institutional Ownership

$11.94
+0.16 (+1.36%)
(As of 10:39 AM ET)

Institutional Ownership Changes (13F Filings) for Iovance Biotherapeutics (NASDAQ:IOVA)

Current
Institutional Ownership
Percentage
77.03%
Number of
Institutional Buyers
(last 12 months)
118
Total
Institutional Inflows
(last 12 months)
$148.92M
Number of
Institutional Sellers
(last 12 months)
49
Total
Institutional Outflows
(last 12 months)
$99.18M
Get IOVA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IOVA Institutional Buying and Selling by Quarter

Iovance Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/29/2024 Principal Financial Group Inc.2,005,905$29.73M0.0%-23.9%0.718%
4/29/2024 China Universal Asset Management Co. Ltd.53,708$796K0.1%+81.4%0.019%
4/25/2024 Shaker Investments LLC OH79,087$1.17M0.5%N/A0.028%
4/23/2024 Rice Hall James & Associates LLC1,713,825$25.40M1.5%-2.1%0.614%
4/23/2024 Raymond James Financial Services Advisors Inc.136,754$2.03M0.0%+5.0%0.049%
4/18/2024 Diversified Trust Co15,511$230K0.0%+14.8%0.006%
4/17/2024 Grimes & Company Inc.29,250$433K0.0%-16.4%0.010%
4/17/2024 Hennion & Walsh Asset Management Inc.407,429$6.04M0.3%+42.4%0.146%
3/11/2024Vanguard Group Inc.22,812,820$185.47M0.0%+3.0%8.168%
3/1/2024Goldman Sachs Group Inc.3,681,560$29.93M0.0%-2.2%1.439%
2/26/2024Perceptive Advisors LLC11,979,415$97.39M2.2%+0.1%4.681%
2/23/2024 Chicago Partners Investment Group LLC20,559$157K0.0%+15.0%0.008%
2/15/2024Opaleye Management Inc.897,000$7.29M2.0%+47.0%0.351%
2/15/2024Boxer Capital LLC1,400,000$11.38M0.6%-62.2%0.547%
2/15/2024Brevan Howard Capital Management LP692,775$5.63M0.1%-55.7%0.271%
2/14/2024Invenomic Capital Management LP1,053,251$8.56M0.4%N/A0.412%
2/14/2024Pale Fire Capital SE17,024$138K0.0%+12.7%0.007%
2/14/2024Sectoral Asset Management Inc.198,800$1.62M0.7%-79.8%0.078%
2/13/2024Rafferty Asset Management LLC1,247,515$10.14M0.0%-16.6%0.487%
2/13/2024Rhenman & Partners Asset Management AB1,116,818$9.08M0.9%+17.6%0.436%
2/12/2024Eagle Asset Management Inc.450,456$3.66M0.0%N/A0.176%
2/12/2024Capstone Investment Advisors LLC20,785$169K0.0%-27.1%0.008%
2/12/2024TD Asset Management Inc257,460$2.09M0.0%-23.4%0.101%
2/12/2024Artisan Partners Limited Partnership4,827,670$39.25M0.1%-4.1%1.886%
2/12/2024Pier 88 Investment Partners LLC27,290$222K0.1%N/A0.011%
2/9/2024Corient Private Wealth LLC367,000$2.98M0.0%+206.3%0.143%
2/9/2024UBS Group AG857,308$6.97M0.0%+255.2%0.335%
2/9/2024Norges Bank1,120,457$9.11M0.0%N/A0.438%
2/8/2024Roanoke Asset Management Corp NY41,140$334K0.1%+16.5%0.016%
2/8/2024Great Lakes Advisors LLC136,183$1.11M0.0%-50.8%0.053%
2/8/2024Panagora Asset Management Inc.346,190$2.82M0.0%+3.7%0.135%
2/8/2024Quadrant Capital Group LLC5,059$41K0.0%+1,227.8%0.002%
2/8/2024Inceptionr LLC13,266$108K0.1%N/A0.005%
2/8/2024Vanguard Personalized Indexing Management LLC15,407$125K0.0%N/A0.006%
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.44,765$354K0.0%+19.4%0.017%
2/7/2024 Principal Financial Group Inc.2,636,327$21.43M0.0%-0.3%1.030%
2/7/2024Dimensional Fund Advisors LP3,516,987$28.60M0.0%-11.6%1.374%
2/7/2024BNP Paribas Financial Markets552,847$4.50M0.0%+83.5%0.216%
2/7/2024Teacher Retirement System of Texas51,598$419K0.0%-18.5%0.020%
2/7/2024 Calton & Associates Inc.12,090$98K0.0%N/A0.005%
Truth about Trump you’ve never heard (Ad)

Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump.

For the full story, click here.
2/7/2024E Fund Management Co. Ltd.66,738$543K0.0%-13.2%0.026%
2/6/2024Charles Schwab Investment Management Inc.1,747,023$14.20M0.0%+3.2%0.683%
2/6/2024 Amalgamated Bank20,936$170K0.0%-6.1%0.008%
2/6/2024Swiss National Bank439,456$3.57M0.0%-10.2%0.172%
2/6/2024New York Life Investment Management LLC56,959$463K0.0%-2.3%0.022%
2/5/2024Victory Capital Management Inc.26,921$219K0.0%+19.1%0.011%
2/5/2024Pekin Hardy Strauss Inc.53,000$431K0.1%-5.4%0.021%
2/5/2024Intellectus Partners LLC116,679$949K0.3%-3.0%0.046%
2/5/2024Russell Investments Group Ltd.8,035$65K0.0%-39.7%0.003%
2/2/2024Parametrica Management Ltd320,276$2.60M4.3%+235.7%0.125%
2/2/2024Bailard Inc.12,700$103K0.0%N/A0.005%
2/1/2024New York State Common Retirement Fund1,021,824$8.31M0.0%-0.5%0.399%
2/1/2024Jennison Associates LLC91,155$741K0.0%N/A0.036%
2/1/2024Handelsbanken Fonder AB55,700$453K0.0%+90.8%0.022%
2/1/2024Signaturefd LLC8,723$71K0.0%+256.6%0.003%
1/31/2024J.W. Cole Advisors Inc.62,292$506K0.0%N/A0.024%
1/30/2024 Zurcher Kantonalbank Zurich Cantonalbank 44,145$359K0.0%+13.2%0.017%
1/30/2024Carnegie Capital Asset Management LLC27,400$223K0.0%+17.1%0.011%
1/25/2024Nisa Investment Advisors LLC7,541$61K0.0%+284.0%0.003%
1/24/2024Mirae Asset Global Investments Co. Ltd.142,946$1.16M0.0%-3.4%0.056%
1/24/2024 Grimes & Company Inc.34,998$285K0.0%+136.9%0.014%
1/24/2024 China Universal Asset Management Co. Ltd.29,602$241K0.0%+365.7%0.012%
1/23/2024 Dumont & Blake Investment Advisors LLC11,500$93K0.0%N/A0.004%
1/18/2024Clear Harbor Asset Management LLC11,000$89K0.0%N/A0.004%
1/16/2024 Raymond James Financial Services Advisors Inc.130,287$1.06M0.0%+48.7%0.051%
1/16/2024 Raymond James & Associates16,910$137K0.0%+29.7%0.007%
1/12/2024SG Americas Securities LLC88,729$721K0.0%-67.9%0.035%
1/8/2024 Diversified Trust Co13,512$110K0.0%+12.3%0.005%
1/5/2024 Exchange Traded Concepts LLC26,603$216K0.0%+34.0%0.010%
12/18/2023Vanguard Group Inc.22,143,470$100.75M0.0%+8.6%8.652%
12/7/2023Hudson Bay Capital Management LP430,200$1.96M0.0%+56.4%0.168%
11/27/2023Banque Pictet & Cie SA633,794$2.88M0.0%+18.7%0.248%
11/15/2023Annandale Capital LLC7,000$32K0.0%N/A0.003%
11/15/2023Sectoral Asset Management Inc.985,000$4.48M0.9%N/A0.385%
11/15/2023Seven Eight Capital LP319,502$1.45M0.2%+141.6%0.125%
11/15/2023Kennedy Capital Management LLC344,042$1.57M0.0%+52.3%0.134%
11/15/2023Kettle Hill Capital Management LLC38,474$175K0.0%N/A0.015%
11/15/2023AXQ Capital LP21,700$99K0.0%N/A0.008%
11/14/2023MPM Bioimpact LLC3,287,397$14.96M4.0%+11.4%1.285%
11/14/2023Profund Advisors LLC250,510$1.14M0.1%+31.1%0.098%
11/14/2023Pale Fire Capital SE15,100$69K0.0%N/A0.006%
11/13/2023Portland Investment Counsel Inc.15,000$68K0.0%N/A0.006%
11/13/2023Algert Global LLC393,776$1.79M0.1%+11.8%0.154%
11/13/2023Mariner LLC371,850$1.69M0.0%+107.3%0.145%
11/13/2023Dark Forest Capital Management LP21,792$99K0.0%-40.1%0.009%
11/13/2023Clear Street Markets LLC7,786$35K0.0%N/A0.003%
11/13/2023Rathbones Group PLC71,154$324K0.0%N/A0.028%
11/13/2023Rhenman & Partners Asset Management AB950,000$4.32M0.5%+11.8%0.371%
11/13/2023Rafferty Asset Management LLC1,496,170$6.81M0.0%+42.1%0.585%
11/13/2023E Fund Management Co. Ltd.76,850$350K0.0%+35.8%0.030%
Trump’s last act as President (Ad)

You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.

For the full story, click here.
11/9/2023Rhenman & Partners Asset Management AB35,000$159K0.0%-95.9%0.014%
11/9/2023Deutsche Bank AG503,287$2.29M0.0%-84.8%0.203%
11/9/2023Artisan Partners Limited Partnership5,036,479$22.92M0.0%+13.8%2.033%
11/8/2023State Board of Administration of Florida Retirement System65,451$298K0.0%+10.8%0.026%
11/8/2023Pathstone Family Office LLC10,519$48K0.0%N/A0.004%
11/8/2023Charles Schwab Investment Management Inc.1,692,533$7.70M0.0%+13.5%0.683%
11/8/2023Swiss National Bank489,356$2.23M0.0%+18.9%0.197%
11/8/2023 Amalgamated Bank22,306$101K0.0%+24.8%0.009%
11/8/2023J.P. Morgan Private Wealth Advisors LLC31,294$142K0.0%+58.4%0.013%
11/8/2023New York Life Investment Management LLC58,273$265K0.0%-13.6%0.024%
(Data available from 1/1/2016 forward)

IOVA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IOVA shares?

During the previous two years, 218 institutional investors and hedge funds held shares of Iovance Biotherapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($185.47M), Farallon Capital Management LLC ($102.82M), Perceptive Advisors LLC ($97.39M), Avoro Capital Advisors LLC ($44.86M), Artisan Partners Limited Partnership ($39.25M), Goldman Sachs Group Inc. ($29.93M), and Principal Financial Group Inc. ($29.73M).Learn more on IOVA's institutional investors.

What percentage of Iovance Biotherapeutics stock is owned by institutional investors?

77.03% of Iovance Biotherapeutics stock is owned by institutional investors. Learn more on IOVA's institutional investor holdings.

Which institutional investors have been buying Iovance Biotherapeutics stock?

Of the 184 institutional investors that purchased Iovance Biotherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($3.20M), Vanguard Group Inc. ($2.42M), Artisan Partners Limited Partnership ($2.37M), Nomura Holdings Inc. ($2.30M), Boxer Capital LLC ($2.20M), Principal Financial Group Inc. ($2.01M), and Pictet Asset Management SA ($1.92M).

How much institutional buying is happening at Iovance Biotherapeutics?

Institutional investors have bought a total of 51,029,520 shares in the last 24 months. This purchase volume represents approximately $428.00M in transactions.

Which Iovance Biotherapeutics major shareholders have been selling company stock?

Of the 100 institutional investors that sold Iovance Biotherapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($2.88M), Deutsche Bank AG ($2.81M), Nikko Asset Management Americas Inc. ($2.74M), Boxer Capital LLC ($2.74M), ARK Investment Management LLC ($2.26M), Franklin Resources Inc. ($2.10M), and Avoro Capital Advisors LLC ($2M).

How much institutional selling is happening at Iovance Biotherapeutics?

Institutional investors have sold a total of 30,875,512 shares in the last 24 months. This volume of shares sold represents approximately $261.89M in transactions.


This page (NASDAQ:IOVA) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners